A股異動丨國瓷材料(300285.SZ)漲逾5% 深圳愛爾創科技擬引入高瓴資本及松柏投資為戰投
格隆匯9月16日丨國瓷材料(300285.SZ)漲逾5%,報41.99元,總市值404億元。國瓷材料昨日公佈,公司全資子公司深圳愛爾創科技有限公司擬引入深圳高瓴醇盈投資諮詢中心(有限合夥)和松柏投資管理(香港)有限公司兩個戰略投資者,並簽署《投資框架協議》。各方一致同意投資者對目標公司進行投資,擬通過以不超過5億元人民幣增資目標公司、不超過2億元人民幣受讓公司持有目標公司股權的方式對目標公司進行投資。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.